Top ▲

Inhibitors of apoptosis (IAP) protein family

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

Overview

Click here for help

« Hide More detailed introduction go icon to follow link

The Inhibitors of apoptosis (IAP) are a family of functionally and structurally related proteins. The human family has eight members: NAIP (BIRC1), BIRC2 (cIAPl), BIRC3 (cIAP2), XIAP (BIRC4), BIRC5 (survivin), BIRC6 (apollon), BIRC7 (livin) and BIRC8. All members of the family contain 1-3 copies of a 70-80 amino acid motif known as BIR (baculovirus IAP repeat). The IAPs have garnered interest as drug targets with antineoplastic [1,4,16] and immunomodulatory [7] potential. Small molecule, antagonistic, peptide mimetics have been described [4,9-10,14].

Targets

Click here for help

NLR family apoptosis inhibitory protein Show summary » More detailed page go icon to follow link

baculoviral IAP repeat containing 2 Show summary » More detailed page go icon to follow link

baculoviral IAP repeat containing 3 Show summary » More detailed page go icon to follow link

X-linked inhibitor of apoptosis Show summary » More detailed page go icon to follow link

baculoviral IAP repeat containing 5 Show summary »

baculoviral IAP repeat containing 6 Show summary »

baculoviral IAP repeat containing 7 Show summary »

baculoviral IAP repeat containing 8 Show summary »

References

Click here for help

Show »

How to cite this family page

Database page citation:

Inhibitors of apoptosis (IAP) protein family. Accessed on 05/11/2024. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=889.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Buneman OP, Faccenda E, Harding SD, Spedding M, Cidlowski JA, Fabbro D, Davenport AP, Striessnig J, Davies JA et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets. Br J Pharmacol. 180 Suppl 2:S1-22.